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Abstract 
The book chapter gives an overview on the natural and synthetic polyesters that are used 
in different medical fields for bonding (suturing, fixation), as closures (covering, 
occlusion), for separation, scaffolds (cellular proliferation), capsulation, as drug deliverer 
(with great potential for controlled drug release), and could be used as prostheses. The 
first requirement for applications is that all monomers released from the polymers during 
the degradation/de-polymerization should be biocompatible. Other important polyester 
characteristics are the degradation rate and the mechanical stability pre-determined by the 
conditions of the synthesis. The chapter summarizes the historical background of the 
polyesters, explains the meaning of the biodegradation, biocompatibility; shortly 
characterizes the most interesting polyesters from the point of view of the synthesis and 
their medical application possibilities. Additional information demonstrates how could be 
the disadvantageous properties (short-time hydrolysis, mechanical instability) improved 
with application of co-monomers or by parallel use of different polymers. An important 
part of the chapter is the description of the synthetic roots with demonstration of their 
advantages and disadvantages. 
 
 
1. Polyesters: a short historical overview 
 
The term polyester refers to compounds containing many ester groups in each molecule. 
In practice, they are polymeric materials containing an ester molecular part as major 
structural components in the main macromolecular chains. The ester groups are involved 
in the main chain either directly, as in the cellulose triacetate, poly(vinyl acetate) and 
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poly(methyl acrylate), or through short side-chains [1]. Thus, polyesters consist of 
repeated units of ester; their general formula is shown below: 
 
where the R means aliphatic and/or aromatic groups, which determines the properties of 
the final polyesters, n refers to the number of the units.  
The ester linkage is well-known in natural polymers. For example the shellac, this 
naturally occurring aliphatic polyester that has been already used in the ancient time, is 
biodegradable. Its application was already mentioned in the Indian epic Mahabharatha, 
written around 3000 BC. This biodegradable resin, which is a mixture of aliphatic 
polyhydroxy acids, has been used in protective coatings [3]. The success of shellac was 
an inspiring example that led Bakeland [3] to develop phenolic resins as substituent and, 
from that time - at the turn of the last century - started the development of the synthetic 
polymer industry. The most well-known and often used man made polyester is the 
polyethylene terephtalate (PET), which is a thermoplastic polymer. In its structure, the R 
group consists of a benzene ring (-C6H4-) and an ethylene unit (-CH2-CH2-). Because of 
the aromatic ring in the main-chain, its biodegradtion is not easy [2]. In contrast to PET, 
aliphatic polyesters, the mostly used and investigated polymers applied mainly in medical 
field, are biodegradable. The synthetic polymers with ester groups and an appropriate 
structure are mostly environmentally degradable. 
  
It is noteworthy to mention that at the beginning of the third millennium the scientists and 
industrial experts turned to examples of the nature and developed bio- and 
environmentally accepteble polymers [4]. The first aliphatic polyesters had low 
molecular weight and poor mechanical properties. Some other examples are the 
dihydroxy-terminated poly(alkylene alkanoates), that found applications in the 
production of polyurethane or, as plasticizers. In the 1960s started the research of the 
poly(L-lactide), homo- and copolymers, as they are biocompatible, biodegradable, and 
bioresorbable materials [5].  
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Polyesters play an importnat role among the degradable polymers due to the potentially 
hydrolysable ester bonds. They represent a large group of the environmentally acceptable 
materials [6]. The lack of good mechanical and physical properties could be improved by 
application of co-monomers that enhance the favorable properties (biodegradation, 
application possibilities etc.).  
 
2. Biodegradable polymers 
 
The term "biodegradable polymer" can be defined on different ways [7]. It can refer to 
polymers, which degrade in biological environment, including any environment where 
biological or biochemical processes occur, regardless of the degradation mechanism. In 
other explanation only those polymers are involved into this group that can degrade in 
biochemical reactions, especially in reactions catalyzed by enzymes. By the German 
standard test method existed since the 1998 biodegradability is entitled “test 
of the compostability of plastics”. Generally the classification for the 
biodegradability is that more than 60% of the organic carbon must be 
converted in laboratory experiments within six months; additionally, under 
real‐life conditions in compost more than 90% of the plastic has to be 
degraded by fragmentation in the size of maximum 2 mm. 
A biomaterial can be defined as a material that interfaces with biological systems to 
evaluate, treat, augment or replace any tissue, organ or function of the body.  
 
The minimal requirements of biomaterials are that they should be: 1. non-toxic, non-
pyrogenic, non-hemolytic, chronically non-inflammative, non-allergenic, non-
carcinogenic and non-teratogenic; 2.effective (functionality, performance, durability); 3. 
sterilizable (by ethylene oxide, irradiation, electron beams, autoclave, dry heating); 4. 
biocompatible (interfacially, mechanically, biologically). 
 
Biopolymers are the main type of biomaterials. Vast examples are for the application of 
biodegradable polymers. According to their degradation properties, biopolymers can be 
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further classified into biodegradable and non-biodegradable biopolymers. Many implants, 
such as bone substitute-, bone fixing- and dental materials that should have long term 
stability in the body. In the recent years, developments in tissue engineering, regenerative 
medicine, gene therapy, and controlled drug delivery have inspired researchers for 
development of biodegradable biomaterials with new properties. Biologically derived and 
synthetic biodegradable biopolymers have attracted a considerable attention [9, 10]. 
In the last two decades of the twentieth century, a paradigm shift took place from 
biostable biomaterials to biodegradable (hydrolytically and/or enzymatically degradable) 
biomaterials for medical and related applications [10]. The biodegradability of a polymer 
depends mainly on its backbone structure. The most important requirement is the 
presence of hydrolysable and/or oxidizable linkages in the backbone. The rate of 
biodegradation of polyesters mainly depends on the type of repetitive units, on the 
compositions, sequence length, molecular geometry, molecular weight, morphology (e.g., 
crystallinity, size of spherules, orientation), on the hydrophilicity, surface area, and 
additives [3]. 
 
 
3. Classification of biodegradable polyesters: natural and synthetic 
Considering the raw materials, the polymers are divided into two groups: 1. 
biodegradable polymers from renewable resources (polymers of microbiological origin, 
synthetic polymers from renewable monomers), 2. biodegradable polymers of non-
renewable resources [8]. 
Considering the application of biodegradable polymers they are classified into three 
groups: ecological, medical and dual application. The other factor of classification is the 
origin; according to that they belong to two groups: natural and synthetic polymers. 
Natural polyesters can be found in nature, in numerous animals and also in plants. In the 
case of bacteria, three types of polymers have been identified: 
1. poly(3-hydroxybutyrate) (PHB) and its co-polymer with related repetitive 
units; 
2. poly(β-malate) poly(L-3-carboxy-3-hydroxypropionate); they have the same 
carbon skeleton as PHB but they are not in the storage reservoir system; 
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3. shellac: secreted by the lac insect and exuded it onto different trees. 
Biopolymers that originate from biological sources, could be divided into four types 
according to the components in the polymers: 1) poly(hydroxyalkanoate), 2) protein and 
poly(amino acid), 3) polysaccharide and 4) nucleotide.  
 
From the point of view of their utilization, the degradability is one of the most important 
characteristic [11].  
Biopolymers of natural origin have been investigated for the preparation and application 
of biomaterials in a range of applications. 
In the modern medical industry the use of polymers as biomaterials is important. The 
biomaterials of either natural or synthetic origin should be biocompatible.  
Before the discussion of the biodegradable biopolymers, a summary of the classification 
of the polymers is presented in Figure 1. 
 
Figure 3.1. Classification of polymers 
The classification is based on the structure, the molecular forces and material source. The 
first group indicates the structure of the molecules, while the second group summarizes 
the forces that define the physical, mechanical and thermal character of the polymers. In 
the third group two main clusters are involved, the natural and synthetic polymers. This 
study is dedicated to the biodegradable polyesters that are/could be used for medical 
applications.  
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Naturally occurring polymers have been utilized for long time; however, their application 
has been restricted because of their limited thermoplastic processability. 
The drawback of natural polymers is that even though they are available in ample 
quantity, there are some limitations for their use such as immunogenecity, difficulty in 
processing, a potential risk of transmitting pathogens, and batch-to-batch variability [12, 
98, 99].  
One of the natural polyesters is the poly(β-hydroxybutyrate), which was chemically 
identified in 1920 and it can be found in some microorganisms as a granular component. 
In some cases, they are copolymers with different alkyl groups in β-position. The natural, 
biodegradable, and biocompatible plastics became of industrial interest because of the  
wide range of applications, such as surgical sutures or packaging containers [13]. 
By the modification of the natural polyesters (e. g. controlled incorporation of repeating 
units with different chain length) tailor-made, well-defined copolymers are prepared with 
a range of material properties. The physical and chemical characteristics are defined by 
the composition. 
The synthetic polymers should be produced in a reproducible manner with good quality 
control.  
 
4. The most common synthetic polyesters 
The polyesters are the most extensively investigated class of biodegradable polymers. 
They are important, because of the synthetic versatility, as well as of the numerous 
monomers that build the polyesters. 
In Table 4.1. some important aliphatic polyesters, their acronyms, and their chemical 
structures are presented. 
 
Several representatives of these polymers are in human applications, as pharmaceutical 
complementary, prosthetics, drug deliveries, and in imaging systems. These polymers are 
recognized by the biological environment in the human body due to the similarity with 
natural polymers. These materials may also avoid the stimulation of chronic 
immunological reactions and toxicity often detected at application of synthetic polymers. 
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Some of the biodegradable polyesters are given in details below. 
 
 
 
Table 4.1. Polyesters, their acronyms, and chemical structures  
 
Polymer Acronym Chemical structure 
Poly(glycolic acid) or poly(glycolide) PGA 
 
Poly(lactic acid) or poly(lactide) PLA 
 
Poly(ε-caprolactone ) PCL 
 
Poly(ethylene succinate) PES 
 
Poly(beta-malic acid) PMLA 
 
Poly(3-hydroxy butyrate) or 
poly(hydroxy butyrate) 
PHB 
 
 
 
4.1. Poly(α-hydroxy esters) 
 
4.1.1. Poly(Glycolic acid) (PGA) 
This was the first biodegradable synthetic polymer used for biomedical application. It is a 
highly crystalline, hydrophobic, linear polyester, which has a high melting point and 
relatively low solubility in organic solvents. Its degradation goes through bulk erosion 
with random hydrolysis of ester bonds. The amorphous phase hydrolyzes first, which is 
followed by the degradation of the crystallized part and the complete hydrolysis needs 
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about 4-12 weeks. Its excellent fibre forming and mechanical properties are due to the 
high crystallinity [14-17]. 
 
4.1.2. Poly(Lactic Acid) (PLA) 
The poly(lactic acid) is also a linear polyester. The presence of an additional methyl 
group in its molecule, compared to the PGA, results in high a hydrophobicity. Because it 
is highly amorphous, it dissolves easily in many organic solvents. As the molecule has a 
stereo center, it exits in L, D and DL form, but the most common is the L one. It has good 
tensile strength; low extension and high modulus (ideal biomaterial for load bearing 
application) and it can also form high strength fibres. Its hydrolysis results in lactic acid. 
It degrades homogeneously by hydrolytic erosion as well as random scission of the ester 
bonds, and its degradation rate is lower than of the poly(glycolic acid). The degradation 
time depends on the molecular weight, crystallinity and porosity. The lactic acid, which is 
released in the citric acid cycle during the degradation, can induce inflammatory reaction 
[18, 19]. 
 
4.1.3. Poly(Lactic-co-Glycolic Acid) (PLGA) 
 
The mechanical and physical properties of the PLGA are controlled by the co-monomers. 
Both the L- and the DL-lactides were used for co-polymerization. Different ratio of 
monomers results in polyesters of tailor-made properties, the polymer with composition 
of 90% glycolic acid and 10% of lactic acid could be used for suture. The degradation 
rate could be decreased by increasing the ratio of lactic acid. The PLGA undergo bulk 
erosion through the hydrolysis of the ester bonds. 
 
There are several other co-polymers fabricated for monofilament sutures, that contain 
hard and soft segments along the polymer backbone for property modulation, like 
poly(glycolic-co-trimethylene carbonate and poly(glycolide-co-caprolactone).  
There are some other co-polymers where the components synergistically improve the 
basic characteristics, e.g. when the poly(lactic-glycolic acid) and poly(ethyleneglycol) are 
used together [25]. In this way tailor-made products are prepared that meet specific 
requirements. 
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4.1.4. Poly(Malic acid) (PMA) 
Due to its low toxicity, non-immunogenicity, and biodegradability, PMA is a promising 
polymeric drug carrier [20, 21]. The PMA-based nanoconjugates contain multiple active 
sites and are ready for further engineering and modification. 
The poly(malic acid) exists in three different forms: 
 
Figure 4.1. Polymeric forms of malic acid 
 
The scheme shows (Figure 4.1.), that the polymerization of malic acid could result in 
poly(β-malic acid) or poly(α-malic acid) as well as in poly(α,β-malic acid). There is no 
significant difference between the structure of poly(β-malic acid) and poly(α-malic acid) 
molecules as they form chains and are more hydrophobic than the poly(α,β-malic acid). 
The latter form is not only more hydrophilic than the two previous forms but can exist in 
chain-like as well as in hyper-branching structure. 
Though there is a possibility to gain poly(malic acid) from natural sources or by 
fermentation [22], it is mainly produced by different synthetic methods, which results in 
significantly different molecular weights of PMAs. The factors that influence the polymer 
characteristics (yield, molecular weight, structure) are the synthesis conditions, the 
number of reaction steps, the cost of chemicals and the purification.  
The PMA is a rigid polymer. In order to soften it, several co-monomers could be built in 
the polymers. One of the best is the β-cyclodextrin. It was experimentally demonstrated 
that with increasing β-cyclodextrin ratio in the polymer the polyester characteristics 
changes significantly. The other advantage of this co-monomer is that the inherent 
 10 
complex formation ability of the β-cyclodextrin allows hosting drug molecules inside its 
toroid structure. Further co-monomers involved in the co-polymers (like resorcinol and 
salicylic acid) enables the polyesters for controlled release of monomers having anti-
inflammatory or antifungal activity [23, 24]. 
 
4.1.5. Polydioxanone 
Polydioxanone facilitates the formation of monofilament sutures. Its degradation goes by 
non-specific scission of the ester back bone. Due to the high crystallinity and 
hydrophobicity it is a moderately degrading polymer. 
 
4.1.6. Polycaprolactone (PCL) 
PCL is interesting polyester as the monomer is cheap; the polymer is synthesized by ring 
opening polymerization. It is highly processible polyester; it dissolves in a wide range of 
organic solvents and has the ability to form miscible blends with wide range of polymers. 
Its degradation is due to the presence of a hydrolytically labile aliphatic ester linkage, but 
the degradation rate is slow. PCL has slow tensile strength and could be used for long-
term drug delivery. Its excellent biocompatibility allows to use is as scaffold for tissue 
engineering. There are several co-polymeric systems, where the PCL component 
improves the properties of the original polymer (the degradation rate of the copolymers 
of caprolactone and DL-lactide is much higher. The copolymers of caprolactone and 
glycolic acid give less stiff fibres). 
4.1.7. Poly (trimethylene carbonate) (PTMC) 
The synthesis of this elastomeric aliphatic polyester goes through ring opening 
polymerization of trimethylene carbonate. It could be used for soft tissue regeneration. 
When the molecular weight is low, it is capable to deliver drugs during its 
biodegradation. In vivo, the degradation goes much quicker than in vitro due to enzymes. 
As a homopolymer it has low mechanical performance, this is the reason that this 
undesired property should be improved by co-polymerization. 
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4.1.8. Poly(butylene succinate) (PBS) and its copolymers 
These materials are white crystalline thermoplastics, belonging to the poly(alkene-
dicarboxylate) family, that are obtained by poly-condensation reactions of glycols, such 
as ethylene glycol and 1,4-butanediol, with aliphatic dicarboxylic acids, such as succinic 
and adipic acid. 
 
5. Synthetic routes to polyesters 
Polyesters are the most extensively investigated class of biodegradable polymers. The 
uniqueness of this class of polymers lies in the immense diversity of monomers and in the 
synthetic versatility. Both homo- and co-polymers of polyesters are potential materials 
for a variety of biomedical applications. To improve the properties and develop novel 
biodegradable materials, one can tailor the polymer architecture of biodegradable and 
biocompatible polyesters and their synthetic analogues.  
 
There are several classifications for the polyester syntheses. One of them is the ring-
opening polymerization, the other goes through condensation and there is a possibility to 
synthesize by catalyzed reaction. Another possible grouping is the ring-opening 
polymerization initiated by metal complexes and the step-by-step polymerization (that 
uses mild chemo/enzymatic catalysis [26]. 
5.1. Ring-opening polymerization 
The ring-opening polymerization of cyclic esters produces biodegradable, bioassimilable 
and renewable polyesters. The problem is that the yield is not high because of the 
numerous reaction steps [27]. 
The ring opening polymerization goes through lactone-polymerization [28, 29]. This 
method results in chain-like polymers with high molecular weight [30-33]. 
The major steps in the polyester production are the follows:  
a) synthesis of the ring monomer (generally benzyl ester of benzyl-malolactonate 
[28] 
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b) polymerization through ring opening, which often follows an anionic mechanism 
when initiators are applied, like tetraalkyl- ammonium benzoate [29] or potassium 
alkanoate in the presence of crown ethers [30, 31]. The catalyst could be stannous 
octoate [34] or enzyme [35]. 
c) The last step is the opening of the ester bond and the removal of the masking 
groups (in case of benzyl ester it goes through catalyzed hydrogenolysis) [30, 31]. 
The end-product is a polymer chain with free carboxylic groups. 
 Other polymers could be synthesized via modification of protecting groups or by 
sequential polymerization [30, 31]. The advantage of this method is the high optical 
purity of the product, but the disadvantage is that the end-product synthesized via 
many steps results in very low yield. 
 
There are significant differences in the molecular weights of polyesters depending on the 
synthesis techniques 
 
5.2. Direct poly-condensation  
In order to disseminate the application of polyesters in the biomedical field, extensive 
research was done on their synthesis by poly-condensation, which is realized in solid 
state. The starting materials, with or without catalysts, are heated and the condensation 
takes place with the formation of the poly-condensates and water as side-product. 
Usually, the reaction time is long and the by-product water is removed continuously. 
In contrast to the ring opening synthesis, the poly-condensation is a simple, one-step/one-
pot reaction resulting in small-, medium- and high molecular weight oligomers and 
polymers; they properties are influenced by the reaction conditions (catalyst, temperature, 
pressure, reaction time, constant removal of the water). This reaction always produces 
α,β-derivatives with hyper-branched structure [35-37]. 
 
In the poly-condensation hydroxyl-mono- and/or diacids react with diols or by lactone-
type heterocycles [38]. The disadvantage of this method is the catalyst, which is generally 
toxic metal oxide (mostly tin-derivatives), but there are already some examples, when 
non-toxic metal oxide was used as catalyst [39]. 
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The direct poly-condensation could run in organic solvent too, e.g. in diphenylether [32], 
or in dimethyl formamide [40]. 
 
This type of synthesis is mainly used for production of poly(malic acid) – one of the very 
important polyesters - from natural chemicals, but these polyesters could also be 
synthesized by fermentation [22]. 
 
5.3. Biotechnological synthesis 
The biotechnological approach uses microorganisms (Penicillum, Cyclopium, Physarium 
Polycephalium, Aureobasidium) [41, 42, 43, 44]. In the fermentative way, when different 
microorganisms convert the monomer molecule into their polymers, the synthesis starts 
either from malic acid or from aspartic acid. This method always results in poly(malic 
acid). The disadvantage of the fermentative method is that the product is a mixture of 
polyesters and some un-reacted monomers; the separation, purification process is 
complicated, as well as the control of the molecular weight is difficult. 
 
 
 
6. Degradation of natural and synthetic polyesters  
 
The biodegradability is important in the field of biomedical application because of the 
biocompatibility in association with the long-term, non-degradable implants. These 
polymers are mainly used as drug delivery devices, scaffolds for tissue regeneration, 
stents, artificial skin, orthopedic implants etc. 
The polymer properties in these classes vary to a high degree; the individual polymers 
could be selected according to the individual requirements. Many natural and synthetic 
polymers fulfill most of the properties, required for biomaterials. However, at biomedical 
applications different requirements should be fulfilled (mechanical strength, degradation 
time, surface properties, physicochemical parameters, degree of cross-linking, presence 
of functional group for modification and tagging, etc.). Some of the applications (such as 
bone grafting and bone repair), requires mechanical stability, in addition to the 
biocompatibility; these polymers are suitable for applications when they withstand to 
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load and have long degradation time. The use of polyesters as surgical dressings, sutures, 
etc. requires varying strength and degradation time, their application depends on the type 
of tissue and the type of injury. In tissue engineering application growth factors are 
considered vital for rapid healing of the tissue. The strategy is to mimic matrix and 
provide the necessary information or signaling for cell attachment, proliferation, and 
differentiation.  
This particular factor is more important, when these materials are used as carriers for 
bioactives, where reproducible delivery is required from the carrier. Usually, polymers 
having higher hydrophobicity sustain the release of bioactive molecules for longer time, 
but sometimes instant release are required upon triggering by the external stimuli, which 
may be present at the target site. If the polymer is the only governing factor for the 
release of bioactive molecules, then a predictable release is considerable important. 
Generally the system releases the active moiety in a zero-order pattern at a predetermined 
rate [45]. Surface-eroding polymers are considered to follow zero-order release kinetics 
and the release rate depends on the type of polymer/monomer.  
Polyesters are widely used as basic materials for the preparation of nano-sized drug 
carriers. They can sustain the release for a longer time, and moreover they have very well 
established safety and disposition profiles from the clinical point of view [46-48]. 
Polyesters mainly undergo bulk erosion, i.e., the polymeric matrices degrade all over 
their cross section and have erosion kinetics that is non-linear and usually characterized 
by a discontinuity. The biodegradable polymers are classified as the Figure 6.1. shows. 
 
 
Figure 6.1. Classification of biodegradable polymers 
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The biodegradable polymers can be classified according to their structure and 
occurrence.  Among the agro-polymers are the polysaccharides, like starch (they consist 
of glycosidic bonds), animal and plant based proteins (built of amino acids). 
Based on the properties, the biodegradable polymers have numerous applications when 
important factors determine their application, stability, durability, and degradability. The 
biodegradable polymers have strong carbon backbones (minimal chain branching 
occurs);  this is the reason that their degradation starts at the end groups. The high surface 
area helps in the degradation by chemicals, enzymes, light etc. at higher rate as they have 
easier access to bounds to cleave. The crystallinity and the hydrophobicity/hydrophilicity 
can also interfere with the degradation process. 
 
6.1. Routes of polymer degradation 
The degradation can be monitored by measuring the change in the molecular weight, 
(which arises from the bond cleavage) or by following the weight loss (which is due to 
depletion of low molecular weight materials). The hydrolytic degradation results not only 
in structural but morphological and topological changes that can be visualized by 
scanning electron microscopy (SEM), but in formation of degraded products 
(determinable by LC-MS, GC-MS), and in changes in mechanical properties. Special 
chromatography (headspace GC-MS, LC, etc.) has been developed for the detection and 
identification of low molecular weight compounds in degraded polymer matrix. By these 
techniques, as Karlsson and Albertsson described [49], the degradation products in PHA, 
PLA, poly(LA-coglycolide) can be well identified. 
The polymer degradation takes place mostly through scission of the main chains or side-
chains of polyesters, which is induced by thermal activation, photolysis, radiolysis, 
hydrolysis or oxidation [51]. It takes place via water uptake when oligomers and finally 
monomers are formed. The first is when the water attacks the water-labile bonds by 
infiltrating into the polymer matrix and then the bond is hydrolyzed [52]. This is a so-
called neutral nucleophilic attack, but the hydrolysis could be catalyzed by acid, base or 
enzymes. 
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Generally, two different mechanisms are discussed in literature for the degradation of 
polyesters: 1) bulk degradation and 2) surface erosion. In the bulk degradation process, 
the water molecules diffuse faster into the polymer matrix than the polymer starts to 
degrade. The result is that the hydrolysable bonds in the whole polymer matrix are 
homogeneously cleaved. Therefore, the average molecular weight of the polymer 
decreases homogeneously. In the case of surface erosion, the diffusion rate of water into 
the polymer matrix is slower than the degradation rate of the macromolecules. The 
degradation takes only place in the thin surface layer while the molecular weight of the 
polymer in the bulk remains unchanged. The surface erosion is a heterogeneous process 
when the rate strongly depends on the shape and the surface area of the test sample [50]. 
The biodegradable natural and synthetic polymers can break down and result in natural 
by-products such as gases (CO2, N2), inorganic salts and biomass. They can have not only 
ester functional groups but amide and ether, too. 
 
6.1.1. Alkali-catalyzed polyester hydrolysis 
 
In this hydrolytic process the hydroxide anion reversible attacks the carbonyl carbon 
atom of the ester group and a tetrahedral intermediate is formed; the ether is involved into 
a tetrahedral intermediate product that can hydrolyze, and alcohol and carboxylic acid are 
formed. The preference of the tetrahedral intermediate toward hydrolysis versus ester 
regeneration is determined by the ability of the leaving alcohol (ROH) that stabilizes the 
negative charge [53]. As a result, one hydroxyl and one carboxyl end groups are 
generated (Figure 6.2.) [54]. 
 
Figure 6.2. Alkaline-catalyzed hydrolysis of polyesters [53] 
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6.1.2. Acid-catalyzed polyester hydrolysis 
 
When acid is present, the degradation of a polyester starts with protonation of the 
carbonyl oxygen of the ester group by the formation of a hydronium ion; thus the 
carbonyl carbon becomes more electrophilic due to the positive charge. Then a water 
molecule attacks the carbonyl carbon, a tetrahedral intermediate is formed, which 
decomposes into carboxylic acid and alcohol (Figure 6.3.). 
 
 
Figure 6.3. Acid-catalyzed hydrolysis of polyesters [53] 
 
6.1.3. Enzymatic degradation of polyesters 
 
In biological environment (river, sea, soil, human and animal body fluid), and when 
microorganisms are present, the polyesters can also hydrolyze [55]. This happens in the 
case of water insoluble polymers, where the degradation rate depends on the molecular 
weights. At high molecular weight the microbes cannot incorporate the polymers but by 
excretion of extracellular enzymes the polymers will be de-polymerized [56]. On the 
other hand, the smaller polymers could be incorporated into the cell and will be 
metabolized by the microorganism. During the de-polymerization water, methane, carbon 
dioxide and biomass are produced [57]. 
 
7. Medical application of biodegradable polyesters  
 
The application of various natural or artificial polymers in the modern medicine is very 
important, which started several decades ago [58]. Some of them stay in the body forever 
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(implants), others only for shorter periods, thus they should be removed or excreted from 
the body. The biodegradable polyesters break down in the body. 
The application of biodegradable polyester is widespread. They could be grouped by the 
functions: bonding (suturing, fixation adhesion); by the closure (covering, occlusion); by 
the separation (contact inhibition, isolation); on the basis of the scaffold (cellular 
proliferation) and the capsulation (controlled drug delivery). 
 
New materials are continuously developed as they should possess desired properties for 
highly specific purposes. Important points at the special chemicals are the physical, 
biochemical and the degradation properties. It is not enough to fulfill one of the 
requirements but almost all at the same time. The processing techniques are also 
important as the procedures, the biopolyesters are formed, could improve one or more of 
the required characteristics. 
There are a lot of advantages in the application of biodegradable polyesters, like easier 
physiological and less invasive repair or the possibility of tissue growth. On the other 
hand, the degradation products could be toxic, they can induce inflammation. The 
sterilization could also be difficult. 
The advantage of biopolymers in the medical application is that the polyesters are tailor-
maid from the point of view of chemical, physical and surface properties. These 
properties improve the in vivo cell adhesion and proliferation as well as allow keeping the 
original characteristics for long time. Additionally their degradation will not take harmful 
effects in the body. 
As it was earlier mentioned, these polyesters have great potential for controlled drug 
delivery, play important role in wound management (suture, and surgical meshes) and are 
applicable for orthopedic devices (screws, pins, and rods) and in tissue engineering. It is 
important is to apply a series of degradable polymers with desired physical, chemical, 
biological, biomechanical and degradation properties with desired physical, chemical, 
biological, biomechanical and degradation properties for surgical sutures, implants etc.. 
In the last years, the highlight is on discovery of new tissue engineers, drug deliverers. 
The poly(glycolic acid) could be used in short-term tissue engineering scaffolds and, as a 
filler, it can be coupled with other degradable polyester, because of the relatively rapid 
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degradation and insolubility in many organic solvents. It is often used in mesh networks 
applied in scaffold for bone, cartilage, tendon, in regeneration of intestinal, lymphatic 
system, and spinal cord. The rapid degradation results in loss of mechanical strength, 
local production of glycolic acid; though it is bioresorbable, but could cause 
inflammation.  
The poly(lactic acid), which degrades slowly is seldom applid for drug delivery. To 
reduce the degradation time, this polyester was modified or co-polymerized. One 
possibility for the modification is the irradiation by beta or gamma rays, when carbon 
radicals are induced which lead to branching and cross-linking; this process results in 
decreased crystallinity. In this form, the polyester could be used for short-term controlled 
delivery application as well as bone fixator. The PLA is extensively utilized in tissue 
engineering as scaffolds for bone, cartilage, neural, and vascular regeneration. Its 
composites e.g. when the PLLA is combined with the raceme PDLLA, the new polyester 
poly(L-lactide-co-PDLLA) is much more applicable because of the amorphous structure. 
 
The random polymerization of PLA and PGA forms poly(lactide-co-glycolide) [59].  
The different PLGAs are applied for meshes, suture reinforcement, skin replacement. 
This is an ideal biomaterial for temporary medical applications (controlled drug delivery, 
tissue engineering). It demonstrates good adhesion and proliferation in tissue engineering 
application. Nanospheres and nanofibers have been developed for controlled drug release. 
This is the most investigated biodegradable polyester for biomedical application. Its 
preparation is easy, and it is used in sutures (since 1974) [60], applicable for tissue 
engineering scaffolds and for drug delivery (e.g. in chemotherapy) [61, 62], for the 
delivery of antibiotics [63-65], anti-inflammatory drugs [66, 67], and analgetics [68, 69]. 
 
The most common representative of the poly(hydroxyalkanoate) group is the poly(3-
hydroxybutyrate), which is a good candidate for a long-term tissue engineering, but not 
really suitable for controlled delivery. The undesired character could be improved by 
copolymerization with PHB. This results in polyesters applicable in tissue engineering of 
bones [70-72], tendon [73], cartilage [74], and skin [75, 76]. For tissue engineering, the 
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collagen based poly(2-hydroxybutyrate-co-4-hydroxybutyrate) could be used where the 
collagen enhances the hydrophilicity. 
 
Poly(caprolactone): Due to the very low in vivo degradation of this semi-crystalline 
polyester and the high drug permeability, it is often used as long-term implant delivery 
device [77]. The PCL has low tensile strength and very high elongation at break, this 
characteristic makes it a good elastic biomaterial [78]. It can be used as it is or in 
composites as tissue engineering scaffolds for bone regeneration [79-81], cartilage [82, 
83], and skin [84, 85]. Surface plasma treatment of the polycaprolactone membrane can 
improve the adhesion and proliferation of human cells [86]. 
 
Poly(propylene fumarate): As this polyester has cross-linking ability, the polymer 
degradation depends on the cross-linking density and the molecular weight. This 
favorable property makes it suitable for biomedical application (bone filling, andlong-
term delivery of ocular drugs [87-89]. 
 
The poly(anhydrides), which are surface eroding polymers, were originally developed as 
textile fibers in 1930s, but the hydrolytic instability did not allow its wide-spread usage. 
Extensive study on the degradation (which depends on the backbone chemistry) led to 
polymers, where the deterioration rate could vary by orders of magnitude, as a result of 
co-monomers used. It helped in the drug delivery application such as chemotherapeutics 
[90, 91], antibiotics [92, 93], and vaccines [94-96]. 
 
The poly(sebacic anhydride) has limited application because of the rapid degradation. 
 
Polyester blended by biomacromolecules: Other possibility to enhance the polyester’s 
biodegradability is the blending by biomacromolecules, like in the case of hyperbranched 
poly(acrylic acid-co-3-hydroxypropionate),, which matrix is good for drug delivery or 
hydrogel scaffold for tissue engineering. 
 
It is essential to mention that not only chemical, physical and mechanical properties 
should be taken into account in the healthcare and medical textiles but other 
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considerations, as their engineering and application is also very important [97]. Also 
major factors are the biocompatibility, biodegradability in the healthcare application as 
well as the hygiene, wound care, grafts, and implantable. The characteristics of the 
biopolyesters are also affected by the structure of textiles (woven, knots, and nonwoven), 
which is related to specific medical uses. 
 
8. Summary 
 
This chapter summarizes the naturally occurring and synthetic polyesters. These synthetic 
biodegradable polyesters that could be used in the medical field are discussed in detail. 
The synthetic routes via these biodegradable polyesters could be prepared are described 
and on the basis of the advantages and disadvantages, one can decide which is favorable 
for the production of the desired product. For example, by ring opening synthesis 
materials with high purity can be synthesized, but the yield is very low because of the 
many synthetic steps. The direct poly-condensation is a simple, one-pot technique with a 
disadvantage that the product is not homogeneous and needs further purification. Detailed 
information about the most important representatives of the synthetic polyesters 
summarizes not only the chemical, physical, and mechanical characteristics but the 
application possibilities together with the field, where they are used. In that case when the 
basic polyester does not have the proper attribute (mechanical, physical etc.) it could be 
further modified and improved by co-polymerization, irradiated) as long as the material 
with the proper characteristic is produced. There are important representatives for suture, 
drug delivery, prosthetic devices, and implants just to mention some of the application 
possibilities of these very important biodegradable polyesters. 
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